Effects of aripiprazole on the steady-state pharmacokinetics of venlafaxine in healthy subjects

Trial Profile

Effects of aripiprazole on the steady-state pharmacokinetics of venlafaxine in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Nov 2013

At a glance

  • Drugs Aripiprazole (Primary) ; Venlafaxine (Primary)
  • Indications Affective disorders; Generalised anxiety disorder; Major depressive disorder; Panic disorder; Psychotic disorders; Social phobia
  • Focus Pharmacokinetics
  • Sponsors Otsuka Pharmaceutical Development & Commercialization
  • Most Recent Events

    • 16 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top